Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VPC171 is a novel adenosine A1 receptor positive allosteric modulator (PAM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 112.00 | |
5 mg | In stock | $ 223.00 | |
10 mg | In stock | $ 319.00 | |
25 mg | In stock | $ 589.00 | |
50 mg | In stock | $ 839.00 | |
100 mg | In stock | $ 1,160.00 | |
500 mg | In stock | $ 2,330.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 227.00 |
Description | VPC171 is a novel adenosine A1 receptor positive allosteric modulator (PAM). |
In vivo | VCP171 produced a greater inhibition of eEPSC amplitude of nerve-injury versus control animals in both lamina I and lamina II neurons[2]. |
Synonyms | VPC 171, VPC-171 |
Molecular Weight | 347.35 |
Formula | C18H12F3NOS |
CAS No. | 1018830-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/ml(57.58 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VPC171 1018830-99-3 GPCR/G Protein Neuroscience Adenosine Receptor VCP171 Lamina II AMPAR Sprague-Dawley rats P1 receptor neuropathic pain VCP-171 inhibit VPC 171 Inhibitor A1R VCP 171 VPC-171 neurons inhibitor